autonomix.com (AMIX): Debts to Book Capitalization

Brandmark of autonomix.com (AMIX)

The debt-to-book capitalization history for Autonomix Medical, Inc. (AMIX) on GURU.Markets exhibits volatility due to the company's reliance on Asian metal and chip supplies. The value 0.00 serves as the baseline for this parameter. Fundamentally, management is developing neuromonitoring systems for pain therapy, while an active R&D pipeline focuses on creating specialized catheters for oncological surgeries.

AMIX - Autonomix Medical Debts to Net Assets over the range 02/21/2024 - 10/27/2026
Original product of autonomix.com

Autonomix Medical, Inc. (AMIX) occupies a specialized niche in medtech, developing precision systems for nerve surgery. This indicator measures the company's reliance on borrowed funds relative to its equity, identifying the risk of asset degradation. It is critical for investors to assess whether the debt load outweighs the value of technological developments. Analyzing the ratio of total debt to book capital helps balance investment protection with growth leverage. The price action on this chart determines the business's financial stability during periods of market volatility.

Competitors of Autonomix Medical, Inc.

BSX: Debts to Book Capitalization|Debts to Book Value edwards.com EW|RMD: Debts to Book Capitalization|PODD - Debt to Book Value|Zimmer Biomet - Debts to Book Capitalization|CooperSurgical (COO) - Debts to Net Assets|ALGN (Align Technology, Inc.) - Debts to Book Capitalization|Debts to Book Capitalization GMED|Debt to Book Capitalization Ratio TransMedics Organ Care System (TMDX)|Debt to Book Capitalization Ratio Alphatec Holdings (ATEC)|Debts to Book Capitalization AORT|ENOV - Debts to Net Assets|Debt to Book Value Integra LifeSciences|ESTA - Debts to Book Capitalization Ratio|Debts to Book Capitalization BBNX|IRADIMED Corp (IRMD) - Debts to Book Value|Debts to Book Capitalization Embecta Inc. (EMBC)|Debt to Book Value Ratio Tandem Corp (TNDM)|AxoGen, Inc. (AXGN) - Debt to Book Value|Debt to Net Assets Ratio SIBN (si-bone.com)|Orthofix - Debt to Book Capitalization Ratio|Debt to Book Value Bioventus Inc BVS|KIDS (OrthoPediatrics Inc.) - Debts to Book Capitalization|TMCI - Debts to Book Value|Debts to Book Capitalization Strata Critical Medical Inc|carlsmed.com (CARL) - Debt to Book Value Ratio|RXST: Debts to Book Capitalization|Debts to Net Assets ClearPoint|Debts to Book Capitalization STXS (Stereotaxis Corp)|Debt to Book Value Neuronetics, Inc (STIM)|Debts to Book Capitalization SGHT (Sight Sciences, Inc.)|Orchestra BioMed Inc. - Debts to Book Capitalization|ANIK - Debt to Book Capitalization Ratio|InspireMD Inc (NSPR) - Debt to Book Capitalization Ratio|Debt to Book Value zhjmedical.com ZJYL|Vivani Medical (VANI) - Debt to Net Assets Ratio|Debts to Book Capitalization XTNT (Xtant Medical Holdings, Inc.)|Debts to Book Value NMTC|MODD: Debt to Book Capitalization Ratio|Debt to Net Assets Myomo Inc. MYO|Debt to Book Value COCH (Envoy Medical, Inc)|Debts to Book Capitalization Vivos Therapeutics Inc VVOS|Debts to Book Capitalization NVNO (enVVeno Medical)|SINT: Debts to Net Assets|Debt to Book Capitalization Ratio Tenon Medical (TNON)|LFWD (ReWalk Robotics) - Debts to Book Capitalization Ratio|Debt to Book Capitalization Ratio IVF|Debt to Book Value Bone Biologics Inc|Axonics, Inc. - Debts to Book Capitalization|Debts to Book Value BIOL (biolase.com)|DYNT - Debt to Book Capitalization Ratio|FNA - Debt to Book Value Ratio|Debt to Book Value INVO Bio INVO